MedPath

A Comparison of Full mouth X-ray assisted nerve block with conventional nerve block technique in Permanent lower molars with Symptomatic Irreversible Pulpitis

Phase 1
Completed
Conditions
Health Condition 1: K040- Pulpitis
Registration Number
CTRI/2022/10/046857
Lead Sponsor
Dr DIKSHIT SOLANKI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
34
Inclusion Criteria

1.Systemically healthy Patients (ASA 1 & 2) between age group of 18-60 years will be included in the study.

2.Patients with pre-operative moderate to severe pain i.e. VAS score of 4 and above in mandibular molars will be included in the study.

3.Patient having fully erupted last tooth in the mandibular arch upto the level of occlusion will be included in the study.

4.Patients showing hyper response to cold and electric pulp testing (EPT) will be included in the study.

5.Patients with symptomatic irreversible pulpitis with/without symptomatic apical periodontitis (only vital teeth) will be included in the study.

6.Patients requiring treatment of multiple teeth along with the concerned tooth will be included in the study.

7.A written informed consent will be taken from all the patients and only those patients ready to sign the consent form will be included in the study.

Exclusion Criteria

1.Asymptomatic Non-Vital Teeth with/without periapical radiolucency be it abscess or granuloma etc will be excluded.

2.Patients showing active sites of pathosis in the injection area.

3.Medically compromised patients will be excluded.

4.Teeth with completely obliterated canals will be excluded

5.Teeth with open apex, root resorption or complex root canal anatomy will be excluded.

6.Teeth with vertical root fractures, cracks, etc will be excluded.

7.Patient with deep periodontal disease or endo-perio lesion with periodontal phase dominant will be excluded.

8.Patients with restricted mouth opening will be excluded.

9.Pregnant and lactating women will be excluded.

10.Patients using medications that might affect the anesthetic assessment will be excluded.

11.Patients allergic to lidocaine and/or adrenaline will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath